EIM
CLB icon

Essex Investment Management’s Core Laboratories CLB Stock Holding History

Essex Investment Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-44,597
Closed -$1.07M – 336
2023
Q3 		$1.07M Buy
+44,597
New +$1.09M 0.17% 187

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Essex Investment Management's CLB Position: Q4 2023 in Review

Essex Investment Management sold out of Core Laboratories (CLB) in Q4 2023, closing a stake of 44,597 shares — an estimated $1.07M sold.

Essex Investment Management first reported a position in CLB in Q3 2023 and held it in 1 quarter. The position peaked at $1.07M in Q3 2023. 186 funds tracked by Wall St. Rank hold CLB as of Q4 2023.

  • Essex Investment Management reported no remaining Core Laboratories position as of Q4 2023 after selling out during the quarter.
  • Essex Investment Management sold 44,597 Core Laboratories shares in Q4 2023, an estimated $1.07M.
  • Essex Investment Management first reported a position in Core Laboratories in Q3 2023 and held it in 1 quarter.
  • Essex Investment Management's Core Laboratories position peaked at $1.07M in Q3 2023.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2023.

Based on Essex Investment Management's 13F filing for Q4 2023, filed 8 Feb 2024.